1. Home
  2. PRVA vs LIVN Comparison

PRVA vs LIVN Comparison

Compare PRVA & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$23.71

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$80.81

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRVA
LIVN
Founded
2007
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
PRVA
LIVN
Price
$23.71
$80.81
Analyst Decision
Buy
Buy
Analyst Count
12
7
Target Price
$31.17
$72.43
AVG Volume (30 Days)
1.1M
513.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
N/A
EPS
0.02
0.40
Revenue
$2,122,842,000.00
N/A
Revenue This Year
$18.19
$9.79
Revenue Next Year
$10.72
$6.63
P/E Ratio
$1,197.00
$202.66
Revenue Growth
22.26
N/A
52 Week Low
$18.92
$41.13
52 Week High
$28.82
$85.27

Technical Indicators

Market Signals
Indicator
PRVA
LIVN
Relative Strength Index (RSI) 34.75 50.87
Support Level $22.78 $61.63
Resistance Level $24.65 $80.96
Average True Range (ATR) 0.94 2.39
MACD -0.48 -0.18
Stochastic Oscillator 4.62 60.77

Price Performance

Historical Comparison
PRVA
LIVN

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: